LINDSAY CELADA to Sarcoidosis
This is a "connection" page, showing publications LINDSAY CELADA has written about Sarcoidosis.
Connection Strength
1.966
-
Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation. Am J Respir Cell Mol Biol. 2017 01; 56(1):74-82.
Score: 0.530
-
The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis. Clin Chest Med. 2015 Dec; 36(4):561-8.
Score: 0.485
-
Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy? Immunotherapy. 2015; 7(1):57-66.
Score: 0.462
-
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8+ T cells. Sci Transl Med. 2023 09 13; 15(713):eade2581.
Score: 0.211
-
PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-?1 production. Sci Transl Med. 2018 09 26; 10(460).
Score: 0.150
-
Molecular Analysis of Sarcoidosis Granulomas Reveals Antimicrobial Targets. Am J Respir Cell Mol Biol. 2016 07; 55(1):128-34.
Score: 0.128